Quantitative risk analyses for RCF: Survey and synthesis

Regulatory Toxicology and Pharmacology

Volumn 38, Issue 3, 2003, Pages 400-416

  Maxim, L Daniel ^a   Yu, C P ^b   Oberdörster, Günter ^c   Utell, Mark J ^c  

^a EVEREST CONSULTING ASSOCIATES   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CERAMICS; HUMAN; LUNG CARCINOMA; LUNG FIBROSIS; MESOTHELIOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; UNITED STATES;

ANIMALIA; CRICETINAE;

EID: 0242624510     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2003.08.003     Document Type: Article

References (55)

1. Armitage P., Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer. 8:1954;1-12.
2. Barr, J.T., 1984. Vinyl chloride and TSCA. In: Catheart, D.C., O'Leary, T.F. (Eds.), Risk Management of Existing Chemicals, Proceedings of a Seminar Conducted on December 8-9, 1983, Sponsored by Chemical Manufacturers Association, Washington, D.C., pp. 129-142 (Chapter 10).
3. Bellmann B., Muhle H., Creutzenberg O., Ernst H., Brown R.C., Sébastien P. Effects of nonfibrous particles on ceramic fiber (RCF1) toxicity in rats. Inhal. Toxicol. 13:2001;101-125.
4. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 420:2002;860-867.
5. Cowie H.A., Wild P., Beck J., Auburtin G., Piekarski C., Massin N., Cherrie J.W., Hurley J.F., Miller B.G., Groat S., Soutar C.A. An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre (RCF) industry. Occup. Environ. Med. 58:2001;800-810.
6. Creutzenberg O., Bellmann B., Muhle H. Biopersistence and bronchoalveolar lavage fluids analysis after a subacute inhalation of rats to various man-made mineral fibres. Ann. Occup. Hyg. 41(S1):1997;213-218.
7. Everest Consulting Associates, Cranbury, NJ., 1996. Refractory Ceramic Fibers: A Substitute Study [Submitted to the U.S. Environmental Protection Agency, Washington, DC, on behalf of the Refractory Ceramic Fibers Coalition (RCFC), 1133 Connecticut Avenue, NW, Suite 1200, Washington, D.C. 20036].
8. Fayerweather W.E., Bender J.E., Hadley J.G., Eastes W. Quantitative risk assessment for a glass fiber insulation product. Regul. Toxicol. Pharmacol. 25:1997;103-120.
9. Filderman, A.E., Matthay, R.A., 1996. Bronchogenic carcinoma. In: Bone, R. (Ed.), Pulmonary and Critical Care Medicine. Mosby Yearbook Part H:1-20.
10. Health Council of the Netherlands: Dutch Expert Committee on Occupational Standards (DECOS), 1995. Man Made Mineral Fibers (MMMF). The Hague: Health Council of the Netherlands, publication no. 1995/02WGD, ISBN: 90-5549-085-7.
11. Health Effects Institute-Asbestos Research (HEI-AR), 1991. Asbestos in Public and Commercial Buildings: A Literature Review and synthesis of Current Knowledge, Cambridge, MA.
12. Hesterberg T.W., Miiller W.C., McConnell E.E., Chevalier J., Hadley J.G., Bernstein D.M., Thévenaz P., Anderson R. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundam. Appl. Toxicol. 20:1993;464-476.
13. Hesterberg T.W., Miiller W.C., Thévenaz P., Anderson R. Chronic inhalation studies of man-made vitreous fibres: characterization of fibres in the exposure aerosol and lungs. Ann. Occup. Hyg. 39(5):1995;637-653.
14. Hodgson J.T., Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann. Occup. Hyg. 44:2000;565-601.
15. International Agency for Research on Cancer (IARC), 1988. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 43, Man-Made Mineral Fibers and Radon. International Agency for Research on Cancer, Lyon, France, pp. 39-171.
16. International Agency for Research on Cancer (IARC), 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 81, Man-Made Vitreous Fibres, Lyon, France, 57, 339.
17. International Life Sciences Institute (ILSI) Workshop Participants, 2000. The relevance of the rat lung response to particle overload for human risk assessment. Inhal. Toxicol. 12 (1/2), 1-149.
18. LeMasters G., Lockey J., Rice C., McKay R., Hansen K., Lu J., Levin L., Gartside P. Radiographic changes among workers manufacturing refractory ceramic fibre and products. Ann. Occup. Hyg. 38:1994;745-751.
19. LeMasters G.K., Lockey J.E., Yiin J.H., Hilbert T.J., Levin L.S., Rice C.H. Mortality of workers occupationally exposed to refractory ceramic fiber. J. Occup. Environ. Med. 45:2003;440-450.
20. Lockey J., Lemasters G., Rice C., Hansen K., Levin L., Shipley R., Spitz H., Wiot J. Refractory ceramic fiber exposure and pleural plaques. Am. J. Respir. Crit. Care Med. 154:1996;1405-1410.
21. Lockey J.E., LeMasters G.K., Levin L., Rice C., Yiin J., Reutman S., Papes D. A longitudinal study of chest radiographic changes of workers in the refractory ceramic fiber industry. CHEST. 121:2002;2044-2051.
22. Mast R.W., McConnell E.E., Hesterberg T.W., Chevalier J., Kotin P., Thévenaz P., Bernstein D.M., Glass L.R., Miiller W., Anderson R. Multiple-dose chronic inhalation toxicity study on size-separated kaolin refractory ceramic fiber in male Fischer 344 rats. Inhal. Toxicol. 7:1995;469-502.
23. Mast R.W., McConnell E.E., Anderson R., Chevalier J., Kotin P., Bernstein D.M., Thévenaz P., Glass L.R., Miiller W.C., Hesterberg T.W. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal. Toxicol. 7:1995;425-467.
24. Mast R.W., Maxim L.D., Utell M.J., Walker A.M. Refractory ceramic fiber: toxicology, epidemiology, and risk analyses - a review. Inhal. Toxicol. 12:2000;359-399.
25. Mast R.W., Yu C.P., Oberdörster G., McConnell E.E., Utell M.J. A retrospective review of the carcinogenicity of refractory ceramic fiber in two chronic Fischer 344 rat inhalation studies: an assessment of the MTD and implications for risk assessment. Inhal. Toxicol. 12:2000;1141-1172.
26. Maxim L.D., McConnell E.E. Interspecies comparisons of the toxicity of asbestos and synthetic vitreous fibers: a weight-of-the-evidence approach. Regul. Toxicol. Pharmacol. 33:2001;319-342.
27. Maxim L.D., Kelly W.P., Walters T., Waugh R. A multiyear workplace-monitoring program for refractory ceramic fibers. Regul. Toxicol. Pharmacol. 20:1994;S200-S215.
28. Maxim L.D., Kelly W.P., Walters T., Waugh R. A multi-year workplace-monitoring program for refractory ceramic fibers. Regul. Toxicol. Pharmacol. 26:1997;156-171.
29. Maxim L.D., Allshouse J.N., Deadman J., Kleck C., Kostka M., Webster D., Class P., Sébastien P. CARE: a European programme for monitoring and reducing refractory ceramic fibre dust at the workplace: initial results. Gefahrst. Reinhalt. L. 58:1998;97-103. Nt 3 B Márz.
30. Maxim L.D., Allshouse J.N., Chen S.H., Treadway J., Venturin D. The development and use of respirator response functions as part of a workplace exposure monitoring program for control of potential respiratory hazards. Regul. Toxicol. Pharmacol. 27:1998;131-149.
31. Maxim L.D., Mast R.W., Utell M.J., Yu C.P., Boymel P.M., Zoitos B.K., Cason J.E. Hazard assessment and risk analysis of two new synthetic vitreous fibers. Regul. Toxicol. Pharmacol. 30:1999;54-74.
32. Maxim L.D., Allshouse J.N., Venturin D.E. The random-effects model applied to refractory ceramic fiber data. Regul. Toxicol. Pharmacol. 32:2000;190-199.
33. Maxim L.D., Allshouse J.N., Chen S.H., Treadway J.C., Venturin D.E. Workplace monitoring of refractory ceramic fiber in the United States. Regul. Toxicol. Pharmacol. 32:2000;293-309.
34. Moolgavkar S.H., Luebeck E.G., Turim J., Hanna L. Quantitative assessment of the risk of lung cancer associated with occupational exposure to refractory ceramic fibers. Risk Anal. 19:1999;599-611.
35. Moolgavkar S.H., Luebeck E.G., Turim J., Brown R.C. Lung cancer risk associated with exposure to man-made fibers. Drug Chem. Toxicol. 23(1):2000;223-242.
36. Regulatory Impact Analysis Projects, Inc. (RIAP), 1994. Choices in Risk Assessment: The Role of Science Policy in the Environmental Risk Management Process [Prepared for Sandia National Laboratories and sponsored by The U.S. Department of Energy, Office of Environmental Management and Office of Environment, Safety and Health, Washington, D.C.].
37. Rice C.H., Lockey J.E., Lemasters G.K., Levin L.L., Staley P., Hansen K.R. Estimation of historical and current employee exposure to refractory ceramic fibers during manufacturing and related operations. Appl. Occup. Environ. Hyg. J. 12:1997;54-61.
38. Rossiter C.E., Chase J.R. Statistical analysis of results of carcinogenicity studies of synthetic vitreous fibres at Research and Consulting Company. Geneva. Ann. Occup. Hyg. 39:1995;759-769.
39. Sciences International, Inc. (SII), 1998. Quantitative Risk Assessment of Refractory Ceramic Fibers in the Occupational Environment, Alexandria, VA.
40. Smith R.S., Smith T.J., Blieden T.M., Phipps R.P. Fibroblasts as sentinel cells: synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151:1997;317-322.
41. U.S. Department of Labor, Occupational Safety and Health Administration (OSHA), 1983. Occupational exposure to ethylene dibromide. Fed. Regist. 48 (196), 45956-46003.
42. U.S. Department of Labor, Occupational Safety and Health Administration (OSHA), 1987. Occupational exposure to benzene. Fed. Regist. 52 (176), 34460-34508.
43. U.S. Department of Labor, Occupational Safety and Health Administration (OSHA), 1996. Occupational exposure to 1,3-butadiene. Fed. Regist. 61 (214), 56746-56856.
44. U.S. Department of Labor, Occupational Safety and Health Administration (OSHA), 1997. Occupational exposure to methylene chloride. Fed. Regist. 62 (7), 1494-1619.
45. U.S. Environmental Protection Agency (EPA), 1986. Guidelines for Carcinogen Risk Assessment. EPA/630/R-00/004.
46. U.S. Environmental Protection Agency (EPA), 1997. Exposure Factors Handbook (Final) Volumes I, II, III. Available from 〈http://www.epa.gov/ ncea〉.
47. U.S. Environmental Protection Agency (EPA), 2000. Benchmark Dose Technical Guidance Document. EPA/630/R-00/001.
48. U.S. Environmental Protection Agency (EPA), 2002. Integrated Risk Information System (IRIS). "Refractory ceramic fibers." Available from 〈 http://www.epa.gov/iris/subst/0647.htm〉.
49. U.S. Environmental Protection Agency (EPA), 2003. Final Draft. Guidelines for Carcinogen Risk Assessment. NCEA-F-0644A. Available from 〈 www.epa.gov/ncea/raf/cancer2003.htm〉.
50. Walker A.M., Maxim L.D., Utell M. Risk analysis for mortality from respiratory tumors in a cohort of refractory ceramic fiber workers. Regul. Toxicol. Pharmacol. 35:2002;95-104.
51. Yu, C.P., Oberdörster, G., 2000. Dose Response and Human Cancer and Non-Cancer Risk Assessment of Inhaled Refractory Ceramic Fibers (RCF) [Submitted to Dr. David Y. Lai, U.S. Environmental Protection Agency, Washington, D.C.].
52. Yu C.P., Zhang L., Oberdörster G., Mast R.W., Maxim D., Utell M.J. Deposition of refractory ceramic fibers (RCF) in the human respiratory tract and comparison with rodent studies. Aerosol Sci. Technol. 23:1995;291-300.
53. Yu C.P., Ding Y.J., Zhang L., Oberdörster G., Mast R.W., Maxim L.D., Utell M.J. Retention modeling of refractory ceramic fibers (RCF) in humans. Regul. Toxicol. Pharmacol. 25:1997;18-25.
54. Zhang Y., Cao H.J., Graf B., Meekins H., Smith T.J., Phipps R.P. Cutting edge: CD40 engagement up-regulates cyclooxygenase-2 expression and prostagladin E2 production in human lung fibroblasts. J. Immunol. 160:1998;1053-1057.
55. Zoitos B.K., de Meringo A., Rouyer E., Thélohan S., Bauer J., Law B., Boymel P.M., Olson J.R., Christensen V.R., Guldberg M., Koenig A.R., Perander M. In-vitro measurement of fiber dissolution rate relevant to biopersistence at neutral pH: an interlaboratory round robin. Inhal. Toxicol. 9:1997;525-540.